Casma Therapeutics

Cambridge, United States

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

$7.6M raised

Mar 2026

Grant

Biotechnology Health Care Therapeutics

Top Investors

Schroders Capital Third Rock Ventures Michael J. Fox Foundation Mirae Asset The Column Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Casma Therapeutics

How much funding has Casma Therapeutics raised?

Casma Therapeutics has raised $7.6M in total funding. The most recent round was Grant. The last funding was announced in March 2026.

Who are Casma Therapeutics's investors?

Casma Therapeutics's investors include Schroders Capital, Third Rock Ventures, Michael J. Fox Foundation, Mirae Asset, The Column Group.

Where is Casma Therapeutics headquartered?

Casma Therapeutics is headquartered in Cambridge, United States.

What does Casma Therapeutics do?

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

What stage is Casma Therapeutics at?

Casma Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2026.

MLA

"Casma Therapeutics — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/casma-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Casma Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/casma-therapeutics

Wikipedia (cite web)

{{cite web |title=Casma Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/casma-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K